{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:57:28Z","timestamp":1791496648141,"version":"4.3.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T00:00:00Z","timestamp":1419292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/nrneurol.2014.250","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T08:14:02Z","timestamp":1419322442000},"page":"72-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Biomarkers for ALS\u2014in search of the Promised Land"],"prefix":"10.1038","volume":"11","author":[{"given":"Adriano","family":"Chi\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"Traynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,23]]},"reference":[{"key":"BFnrneurol2014250_CR1","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1474-4422(14)70222-4","volume":"13","author":"ME Cudkowicz","year":"2014","unstructured":"Cudkowicz, M. E.  et al. Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 13, 1083\u20131091 (2014).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol2014250_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/ene.12344","volume":"21","author":"T Lenglet","year":"2014","unstructured":"Lenglet, T.  et al. A phase II\u2013III trial of olesoxime in subjects with amyotrophic lateral sclerosis. Eur. J. Neurol. 21, 529\u2013536 (2014).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2014250_CR3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nn.3688","volume":"17","author":"JO Johnson","year":"2014","unstructured":"Johnson, J. O.  et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 17, 664\u2013666 (2014).","journal-title":"Nat. Neurosci."},{"key":"BFnrneurol2014250_CR4","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1093\/brain\/awu138","volume":"137","author":"S Bannwarth","year":"2014","unstructured":"Bannwarth, S.  et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain 137, 2329\u20132345 (2014).","journal-title":"Brain"},{"key":"BFnrneurol2014250_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.neuron.2014.09.027","volume":"84","author":"BN Smith","year":"2014","unstructured":"Smith, B. N.  et al. Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron 84, 324\u2013331 (2014).","journal-title":"Neuron"},{"key":"BFnrneurol2014250_CR6","doi-asserted-by":"publisher","first-page":"e75091","DOI":"10.1371\/journal.pone.0075091","volume":"8","author":"J Gaiottino","year":"2013","unstructured":"Gaiottino, J.  et al. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS ONE 8, e75091 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2014250_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1001\/jamaneurol.2013.6064","volume":"71","author":"M Grossman","year":"2014","unstructured":"Grossman, M.  et al. Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis. JAMA Neurol. 71, 442\u2013448 (2014).","journal-title":"JAMA Neurol."},{"key":"BFnrneurol2014250_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/acn3.30","volume":"1","author":"BR Foerster","year":"2014","unstructured":"Foerster, B. R.  et al. Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 1, 107\u2013114 (2014).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"BFnrneurol2014250_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1212\/WNL.0000000000000792","volume":"83","author":"M Pagani","year":"2014","unstructured":"Pagani, M.  et al. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis. Neurology 83, 1067\u20131074 (2014).","journal-title":"Neurology"},{"key":"BFnrneurol2014250_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jamaneurol.2014.62","volume":"71","author":"K Van Laere","year":"2014","unstructured":"Van Laere, K.  et al. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study. JAMA Neurol. 71, 553\u2013561 (2014).","journal-title":"JAMA Neurol."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2014.250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2014.250","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2014.250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:14:35Z","timestamp":1684469675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2014.250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,23]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFnrneurol2014250"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2014.250","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,23]]},"assertion":[{"value":"23 December 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.C. serves on scientific advisory boards for Cytokinetics, Biogen Idec, and Italfarmaco. B.J.T. holds a patent on methods to screen for the hexanucleotide repeat expansion in C9ORF72.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}